The Academy of Oncology Nurse Navigators white paper, "Assessing the Creative Application and Usefulness of NSider: A Tactical Tool for the Oncology Nurse Navigator" was published in the journal, The Oncology Nurse-APN/NP.

Detailed study of living cells challenges classic gene regulation modelPhys.orgIn all living organisms, genes are regulated by proteins called transcription factors. The established model states that a gene is switched off as long as a repressing transcription factor is bound to the DNA. For the first time ever, researchers at Uppsala University, Sweden, have been able to study the process in living cells, showing that it may be more complex than previously thought.

Modern genes reveal 100 major population shifts in human historyPopular ScienceViolence and love, conquest and assimilation, they're all in your DNA. Literally. As human populations have moved around the world, they've left bits of their genes to mark their passage. We've reported on this before, as scientists have used genes to trace immigrations in the Caribbean and the Indian subcontinent. Now, an ambitious new project has attempted to use genetics to identify many of the major movements of humans over the last 4,000 years. No problem, right?

Is genetic testing humans playing God?CNN"It's a miracle," she told me. "We can now have a baby that won't have Huntington's disease. I thought I'd never be able to have any kids — because of the disease." Her father had died from this disorder, which results from a gene mutation. She feared that she might have the mutation, too. But she was too scared to undergo testing for it. She also worried that if she had it, she might pass it on to her children.

Study highlights the importance of personalized medicine for treating cancerNews-Medical.netIf a driver is traveling to New York City, I-95 might be their route of choice. But they could also take I-78, I-87 or any number of alternate routes. Most cancers begin similarly, with many possible routes to the same disease. A new study found evidence that assessing the route to cancer on a case-by-case basis might make more sense than basing a patient's cancer treatment on commonly disrupted genes and pathways.

Personalized medicine a cost-effective way to tailor drug therapy after stentsHealth CanalGenetic testing can help doctors choose the most effective and economical drugs to prevent blood clots in the half a million patients in the U.S. who receive coronary stents each year, according to a new study led by a UC San Francisco researcher. The work, reported in the February 18, 2014 Annals of Internal Medicine, demonstrates that genetically guided personalized medicine, often perceived as pricier than traditional approaches, can both lower costs and increase the quality of healthcare.

US issues patent for a fraudulent human embryonic stem cell methodForbesAt first I thought the Patent Office was having a little fun. Was it an April Fools Day joke? No, it's only February — and the U.S. Patent Office never kids around. What did they do? They issued a patent to Korean scientist Woo-Suk Hwang for a method to create human embryonic stem cells by cloning. The problem is, Hwang's "invention" was one of the most famous frauds of the past decade.

'Largest ever' trial of adult stem cells in heart attack patients beginsMedical New TodayThe largest ever trial of adult stem cell therapy in heart attack patients has begun at The London Chest Hospital in the U.K. Heart disease is the world's leading cause of death. Globally, more than 17 million people died from heart disease last year. In the U.S., over 1 million people suffer a heart attack each year, and about half of them die.

10 ways mobile technology will save your life in the futureCNNThe medical and healthcare sectors are in the midst of rapid change, and it can be difficult to see which new technologies will have a long-lasting impact. Ideally, the future of healthcare will balance innovative medical technologies with the human touch. Here, I've outlined the trends most likely to change our lives, now or in the near future.

Scientists: Your diet may not fit your genesFox NewsYou are what you eat, and what you eat could be making you age prematurely; in fact, it may even be killing you. And it's not all about 64-ounce cups of sugary soda pop.

How to bring the price of healthcare into the openThe Wall Street JournalIt's a simple idea, but a radical one. Let people know in advance how much healthcare will cost them — and whether they can find a better deal somewhere else. With outrage growing over incomprehensible medical bills and patients facing a higher share of the costs, momentum is building for efforts to do just that. Price transparency, as it is known, is common in most industries but rare in healthcare, where "charges," "prices," "rates" and "payments" all have different meanings and bear little relation to actual costs.

Private exchange sees surge in healthcare enrollmentUSA TodayThe number of customers on the nation's largest private health insurance exchange increased by 50 percent in the final three months of 2013, a direct result of demand created by the Affordable Care Act, the company's CEO said. Gary Lauer, CEO of eHealth Insurance, said individual memberships rose 50 percent in the fourth quarter of 2013 compared with the same period in 2012, from 113,600 applications in the last three months of 2012 to 169,800 in 2013.

Choosing health coverage as deadline nearsThe New York TimesIf you don't have health insurance, there is still time to enroll through the public marketplaces created by the Affordable Care Act. But don't delay too long: The deadline for obtaining coverage for this year is March 31. With six weeks left in the open enrollment period, the numbers of people signing up for coverage are growing.

FDA gives Bristol-Myers' hepatitis drug 'breakthrough' designationFoxBusinessBristol-Myers Squibb's investigational treatment for hepatitis C infection was awarded "breakthrough therapy designation" by U.S. drug regulators. The U.S. Food and Drug Administration has only approved four breakthrough therapies since the FDA's Safety and Innovation Act was signed into law in July 2012.

FDA considers 3-person embryo fertilizationTIMEThe FDA is considering an experimental fertilization technique that makes it possible to create a baby from the DNA of three people, with the goal to bypass genetic disorders from the mother.
The FDA will weigh both sides of the case for a procedure that could prevent mothers from passing along genetic diseases, but also open the door to the possibility of designer babies, experts and critics argue.

This edition of the Genomics Biotech and Emerging Medical Technologies Institute eBrief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!